Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
129.6 USD | -0.80% | +1.90% | +13.30% |
Apr. 22 | RBC Capital Adjusts Xylem Price Target to $157 From $153 | MT |
Apr. 18 | Oppenheimer Adjusts Price Target on Xylem to $142 From $133, Outperform Rating Kept | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.30% | 31.59B | |
+8.99% | 82.5B | |
+18.31% | 70.16B | |
+18.15% | 37.32B | |
+7.43% | 28.13B | |
+2.25% | 26.77B | |
+1.97% | 26.3B | |
+14.45% | 24.99B | |
+16.44% | 23.55B | |
+15.29% | 16.48B |
- Stock Market
- Equities
- XYL Stock
- News Xylem Inc.
- Credit Suisse Adjusts Xylem's Price Target to $111 from $105, Keeps Underperform Rating